| Literature DB >> 31490315 |
Boon Mathew1, Archi Agrawal1, Nilendu C Purandare1, Mukta Ramadwar2, Santosh Menon2, Ganesh Bakshi3, Amit Joshi4, Ameya Puranik1, Sneha Shah1, Venkatesh Rangarajan1.
Abstract
Ga prostate-specific membrane antigen (PSMA) PET/CT is used in the staging, evaluation of biochemical recurrence, and response assessment of patients with prostate cancer. In addition to the PSMA-expressing prostate cancer cells, Ga-PSMA binds to the neovasculaature of various other solid tumors and benign lesions. We report a case of a 72-year-old man with recently diagnosed adenocarcinoma of prostate, incidentally found to have pleomorphic sarcoma on the staging Ga-PSMA PET/CT.Entities:
Mesh：
Substances：
Year: 2020 PMID： 31490315 DOI： 10.1097/RLU.0000000000002760
Source DB: PubMed Journal: Clin Nucl Med ISSN： 0363-9762 Impact factor: 7.794